These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 26873693)
1. Adherence to Antihypertensive Medication in Treatment-Resistant Hypertension Undergoing Renal Denervation. Schmieder RE; Ott C; Schmid A; Friedrich S; Kistner I; Ditting T; Veelken R; Uder M; Toennes SW J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873693 [TBL] [Abstract][Full Text] [Related]
2. Adherence to Antihypertensive Treatment and the Blood Pressure-Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial. Azizi M; Pereira H; Hamdidouche I; Gosse P; Monge M; Bobrie G; Delsart P; Mounier-Véhier C; Courand PY; Lantelme P; Denolle T; Dourmap-Collas C; Girerd X; Michel Halimi J; Zannad F; Ormezzano O; Vaïsse B; Herpin D; Ribstein J; Chamontin B; Mourad JJ; Ferrari E; Plouin PF; Jullien V; Sapoval M; Chatellier G; Circulation; 2016 Sep; 134(12):847-57. PubMed ID: 27576780 [TBL] [Abstract][Full Text] [Related]
3. Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure. Fadl Elmula FE; Hoffmann P; Fossum E; Brekke M; Gjønnæss E; Hjørnholm U; Kjær VN; Rostrup M; Kjeldsen SE; Os I; Stenehjem AE; Høieggen A Hypertension; 2013 Sep; 62(3):526-32. PubMed ID: 23836798 [TBL] [Abstract][Full Text] [Related]
4. Impact of Medication Adherence on the Effect of Renal Denervation: The SYMPATHY Trial. de Jager RL; de Beus E; Beeftink MM; Sanders MF; Vonken EJ; Voskuil M; van Maarseveen EM; Bots ML; Blankestijn PJ; Hypertension; 2017 Apr; 69(4):678-684. PubMed ID: 28264922 [TBL] [Abstract][Full Text] [Related]
5. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. Kandzari DE; Böhm M; Mahfoud F; Townsend RR; Weber MA; Pocock S; Tsioufis K; Tousoulis D; Choi JW; East C; Brar S; Cohen SA; Fahy M; Pilcher G; Kario K; Lancet; 2018 Jun; 391(10137):2346-2355. PubMed ID: 29803589 [TBL] [Abstract][Full Text] [Related]
6. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension. Fadl Elmula FE; Hoffmann P; Larstorp AC; Fossum E; Brekke M; Kjeldsen SE; Gjønnæss E; Hjørnholm U; Kjaer VN; Rostrup M; Os I; Stenehjem A; Høieggen A Hypertension; 2014 May; 63(5):991-9. PubMed ID: 24591332 [TBL] [Abstract][Full Text] [Related]
7. Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis. Ewen S; Meyer MR; Cremers B; Laufs U; Helfer AG; Linz D; Kindermann I; Ukena C; Burnier M; Wagenpfeil S; Maurer HH; Böhm M; Mahfoud F Clin Res Cardiol; 2015 Dec; 104(12):1097-105. PubMed ID: 26306594 [TBL] [Abstract][Full Text] [Related]
8. Screening for non-adherence to antihypertensive treatment as a part of the diagnostic pathway to renal denervation. Patel P; Gupta PK; White CM; Stanley AG; Williams B; Tomaszewski M J Hum Hypertens; 2016 Jun; 30(6):368-73. PubMed ID: 26446393 [TBL] [Abstract][Full Text] [Related]
9. Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension). Gosse P; Cremer A; Pereira H; Bobrie G; Chatellier G; Chamontin B; Courand PY; Delsart P; Denolle T; Dourmap C; Ferrari E; Girerd X; Michel Halimi J; Herpin D; Lantelme P; Monge M; Mounier-Vehier C; Mourad JJ; Ormezzano O; Ribstein J; Rossignol P; Sapoval M; Vaïsse B; Zannad F; Azizi M Hypertension; 2017 Mar; 69(3):494-500. PubMed ID: 28115517 [TBL] [Abstract][Full Text] [Related]
10. Effect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results From the TARGET BP I Randomized Clinical Trial. Kandzari DE; Weber MA; Pathak A; Zidar JP; Saxena M; David SW; Schmieder RE; Janas AJ; Langer C; Persu A; Mendelsohn FO; Ameloot K; Foster M; Fischell TA; Parise H; Mahfoud F Circulation; 2024 Jun; 149(24):1875-1884. PubMed ID: 38587557 [TBL] [Abstract][Full Text] [Related]
11. Renal denervation in moderate treatment-resistant hypertension. Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901 [TBL] [Abstract][Full Text] [Related]
12. The effect of renal denervation in moderate treatment-resistant hypertension with confirmed medication adherence. Ott C; Mahfoud F; Schmid A; Ewen S; Toennes SW; Meyer MR; Helfer AG; Maurer HH; Ditting T; Veelken R; Zivanovic I; Uder M; Böhm M; Schmieder RE J Hypertens; 2016 Dec; 34(12):2475-2479. PubMed ID: 27607458 [TBL] [Abstract][Full Text] [Related]
13. Medication adherence in patients with apparent resistant hypertension: findings from the SYMPATHY trial. de Jager RL; van Maarseveen EM; Bots ML; Blankestijn PJ; Br J Clin Pharmacol; 2018 Jan; 84(1):18-24. PubMed ID: 28815689 [TBL] [Abstract][Full Text] [Related]
14. Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program. Azizi M; Sharp ASP; Fisher NDL; Weber MA; Lobo MD; Daemen J; Lurz P; Mahfoud F; Schmieder RE; Basile J; Bloch MJ; Saxena M; Wang Y; Sanghvi K; Jenkins JS; Devireddy C; Rader F; Gosse P; Claude L; Augustin DA; McClure CK; Kirtane AJ; Circulation; 2024 Mar; 149(10):747-759. PubMed ID: 37883784 [TBL] [Abstract][Full Text] [Related]
15. Central pulse pressure predicts BP reduction after renal denervation in patients with treatment-resistant hypertension. Ott C; Schmid A; Toennes SW; Ditting T; Veelken R; Uder M; Schmieder RE EuroIntervention; 2015 May; 11(1):110-6. PubMed ID: 25982653 [TBL] [Abstract][Full Text] [Related]
16. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial. Azizi M; Sapoval M; Gosse P; Monge M; Bobrie G; Delsart P; Midulla M; Mounier-Véhier C; Courand PY; Lantelme P; Denolle T; Dourmap-Collas C; Trillaud H; Pereira H; Plouin PF; Chatellier G; Lancet; 2015 May; 385(9981):1957-65. PubMed ID: 25631070 [TBL] [Abstract][Full Text] [Related]
17. Effect of Catheter-Based Renal Denervation on Morning and Nocturnal Blood Pressure: Insights From SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan. Kario K; Bhatt DL; Brar S; Cohen SA; Fahy M; Bakris GL Hypertension; 2015 Dec; 66(6):1130-7. PubMed ID: 26558819 [TBL] [Abstract][Full Text] [Related]
18. Clinic Versus Ambulatory Blood Pressure in Resistant Hypertension: Impact of Antihypertensive Medication Nonadherence: A Post Hoc Analysis the DENERHTN Study. Hamdidouche I; Gosse P; Cremer A; Lorthioir A; Delsart P; Courand PY; Denolle T; Halimi JM; Girerd X; Ormezzano O; Rossignol P; Pereira H; Azizi M; Hypertension; 2019 Nov; 74(5):1096-1103. PubMed ID: 31995406 [TBL] [Abstract][Full Text] [Related]
19. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study. Kaltenbach B; Franke J; Bertog SC; Steinberg DH; Hofmann I; Sievert H Catheter Cardiovasc Interv; 2013 Feb; 81(2):335-9. PubMed ID: 22807098 [TBL] [Abstract][Full Text] [Related]
20. Importance of thorough investigation of resistant hypertension before renal denervation: should compliance to treatment be evaluated systematically? Rosa J; Zelinka T; Petrák O; Štrauch B; Šomlóová Z; Indra T; Holaj R; Čurila K; Toušek P; Šenitko M; Widimský P; Widimský J J Hum Hypertens; 2014 Nov; 28(11):684-8. PubMed ID: 24500722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]